Pacific Heights Asset Management Has Cut By $3.75 Million Its Kimco Rlty (KIM) Holding; Marinus Pharmaceuticals (MRNS) Shorts Down By 15.2%

July 17, 2017 - By marketbeat

Pacific Heights Asset Management Llc decreased Kimco Rlty Corp (KIM) stake by 37.5% reported in 2016Q4 SEC filing. Pacific Heights Asset Management Llc sold 150,000 shares as Kimco Rlty Corp (KIM)’s stock declined 23.76%. The Pacific Heights Asset Management Llc holds 250,000 shares with $6.29M value, down from 400,000 last quarter. Kimco Rlty Corp now has $8.16B valuation. The stock increased 1.17% or $0.22 on July 14, reaching $18.95. About shares traded. Kimco Realty Corp (NYSE:KIM) has declined 31.73% since July 17, 2016 and is downtrending. It has underperformed by 48.43% the S&P500.

Marinus Pharmaceuticals Incorporated (NASDAQ:MRNS) had a decrease of 15.2% in short interest. MRNS’s SI was 2.04 million shares in July as released by FINRA. Its down 15.2% from 2.40 million shares previously. With 129,100 avg volume, 16 days are for Marinus Pharmaceuticals Incorporated (NASDAQ:MRNS)’s short sellers to cover MRNS’s short positions. The SI to Marinus Pharmaceuticals Incorporated’s float is 13.05%. The stock increased 5.19% or $0.07 on July 14, reaching $1.42. About shares traded. Marinus Pharmaceuticals Inc (NASDAQ:MRNS) has declined 74.89% since July 17, 2016 and is downtrending. It has underperformed by 91.59% the S&P500.

Investors sentiment is 1.07 in 2016 Q4. Its the same as in 2016Q3. It has no change, as 42 investors sold KIM shares while 120 reduced holdings. only 48 funds opened positions while 126 raised stakes. 382.87 million shares or 0.42% more from 381.28 million shares in 2016Q3 were reported. Royal National Bank Of Canada has invested 0% in Kimco Realty Corp (NYSE:KIM). Hartford Invest stated it has 102,952 shares. Grace & White reported 77,202 shares or 0.42% of all its holdings. Nomura Asset Mgmt Ltd owns 0.16% invested in Kimco Realty Corp (NYSE:KIM) for 347,723 shares. 134,843 were reported by Citadel Advsrs Lc. Comerica Bankshares stated it has 0.03% of its portfolio in Kimco Realty Corp (NYSE:KIM). Moreover, Great West Life Assurance Can has 0.04% invested in Kimco Realty Corp (NYSE:KIM) for 498,623 shares. Connecticut-based Bridgewater LP has invested 0.02% in Kimco Realty Corp (NYSE:KIM). Natixis Asset Mngmt has invested 0.07% in Kimco Realty Corp (NYSE:KIM). Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 106,397 shares or 0.12% of the stock. Old Mutual Customised Solutions (Proprietary) invested 0.07% of its portfolio in Kimco Realty Corp (NYSE:KIM). Kcg has invested 0.05% of its portfolio in Kimco Realty Corp (NYSE:KIM). Retirement Systems Of Alabama owns 0.03% invested in Kimco Realty Corp (NYSE:KIM) for 207,341 shares. Moreover, Huntington National Bank has 0% invested in Kimco Realty Corp (NYSE:KIM). Murphy Capital Inc has invested 0.03% in Kimco Realty Corp (NYSE:KIM).

Analysts await Kimco Realty Corp (NYSE:KIM) to report earnings on July, 26 after the close. They expect $0.38 EPS, 0.00% or $0.00 from last year’s $0.38 per share. KIM’s profit will be $163.63M for 12.47 P/E if the $0.38 EPS becomes a reality. After $0.37 actual EPS reported by Kimco Realty Corp for the previous quarter, Wall Street now forecasts 2.70% EPS growth.

Among 12 analysts covering Kimco Realty (NYSE:KIM), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Kimco Realty had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, November 25 by Argus Research. The firm has “Hold” rating given on Wednesday, August 17 by Deutsche Bank. The stock of Kimco Realty Corp (NYSE:KIM) has “Outperform” rating given on Monday, March 13 by Robert W. Baird. The stock of Kimco Realty Corp (NYSE:KIM) has “Outperform” rating given on Monday, January 9 by Raymond James. Argus Research upgraded Kimco Realty Corp (NYSE:KIM) rating on Wednesday, December 16. Argus Research has “Buy” rating and $29 target. The firm has “Overweight” rating given on Thursday, August 11 by JP Morgan. The firm has “Neutral” rating by JP Morgan given on Friday, December 16. On Tuesday, November 29 the stock rating was downgraded by Goldman Sachs to “Sell”. The firm has “Overweight” rating given on Tuesday, December 15 by Barclays Capital. The firm earned “Hold” rating on Tuesday, September 8 by Evercore.

Since February 13, 2017, it had 3 insider buys, and 1 insider sale for $453,464 activity. $160,124 worth of Kimco Realty Corp (NYSE:KIM) shares were sold by LOURENSO FRANK. On Monday, February 13 the insider COOPER MILTON bought $120,346. COVIELLO PHILIP E JR bought 7,500 shares worth $145,812.

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $33.74 million. The Firm focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. It currently has negative earnings. The Company’s clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.

Investors sentiment decreased to 1 in Q4 2016. Its down 0.08, from 1.08 in 2016Q3. It dropped, as 5 investors sold Marinus Pharmaceuticals Inc shares while 3 reduced holdings. 0 funds opened positions while 8 raised stakes. 4.88 million shares or 19.03% less from 6.03 million shares in 2016Q3 were reported. Manufacturers Life The holds 0% or 161 shares. Creative Planning, Kansas-based fund reported 51,000 shares. Panagora Asset Incorporated reported 0% of its portfolio in Marinus Pharmaceuticals Inc (NASDAQ:MRNS). Geode Lc, a Massachusetts-based fund reported 55,834 shares. Art Ltd holds 16,830 shares or 0% of its portfolio. Sphera Funds Mgmt has 1.34M shares for 0.34% of their portfolio. Next Financial Group Inc accumulated 0% or 2,670 shares. Northern Tru Corp reported 21,470 shares. Blackrock Institutional Na reported 116,511 shares stake. Blackrock Fund Advisors holds 101,703 shares or 0% of its portfolio. Blackrock Mngmt Lc accumulated 0% or 2,024 shares. 186,821 are held by Vanguard Grp Incorporated. Kcg has invested 0% in Marinus Pharmaceuticals Inc (NASDAQ:MRNS). Bridgeway Management Inc owns 30,000 shares for 0% of their portfolio. Capital Guardian Trust Communications stated it has 4,120 shares or 0% of all its holdings.

Among 4 analysts covering Marinus Pharmaceuticals (NASDAQ:MRNS), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Marinus Pharmaceuticals had 9 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Wednesday, August 10. The firm earned “Buy” rating on Tuesday, November 17 by Jefferies. The company was initiated on Thursday, December 17 by RBC Capital Markets. As per Tuesday, March 8, the company rating was maintained by Stifel Nicolaus. Jefferies maintained the shares of MRNS in report on Tuesday, June 14 with “Buy” rating. The firm has “Outperform” rating given on Wednesday, August 5 by Oppenheimer. The firm has “Outperform” rating given on Friday, October 30 by Oppenheimer. Oppenheimer downgraded Marinus Pharmaceuticals Inc (NASDAQ:MRNS) on Tuesday, June 14 to “Perform” rating. On Tuesday, June 14 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: